Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Proposed $25 Million Settlement Reached in Tezos Securities Litigation Pending in United States District Court for the Northern District of California 2020-06-01 21:00
Infinitus supports poverty alleviation in four areas of Southern Xinjiang 2020-06-01 20:30
GTKonnect professionals join EY in expansion of global trade management services 2020-06-01 20:04
Specialty Chemical Company China XD Plastics Announces Fourth Quarter and Fiscal Year 2019 Financial Results 2020-06-01 19:30
Fullerton Fund Management Appoints General Manager for China 2020-06-01 19:14
NetDragon and KONKA Introduce New Smart Education Panel 2020-06-01 17:04
Yunnan Cambrian Town Happy World Offers Family-centric Holiday Experience with The Opening of New Dolphin Bay Hotel 2020-06-01 16:48
DevOps Enterprise Summit London Unveils Virtual Program that Promises to Engage Attendees Through a Dynamic Learning Experience for the DevOps Community 2020-06-01 16:03
OneSmart Recognized with China Best Employer Campus Recruitment Award 2020 2020-06-01 16:00
Fang to Report First Quarter 2020 Financial Results on June 4, 2020 2020-06-01 15:26
UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide 2020-06-01 11:53
YouTrip Partners Withlocals to Bring Virtual Travel to Singaporeans With Over 100 Unique Experiences in 50 Destinations 2020-06-01 09:30
Magellan Financial Group Limited Adopts BasisCode Compliance System in Australia 2020-06-01 09:00
Singaporeans Can Win Cash Worth Up To $1,000 And Donate Credits To Healthcare Workers With PolicyPal's MoneyBag Game 2020-06-01 08:15
FP Markets Celebrates Its 15 Year Anniversary 2020-06-01 07:48
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
Establishment of the Blue Apple New Frontier Healthcare Fund 2020-06-01 07:00
1 1077 1078 1079 1080 1081 2982